These findings are in line with reports in cancer cell lines and primary cells from mucolipidosis type IV patients, a disease caused by TRPML1 loss-of-function mutations and characterized by mitochondrial fragmentation (15, 17). This evidence concerns the gene MCOLN1 and mucolipidosis type IV.